He reiterated that his vaccine is “highly safe that provides lasting protection -more than six months-, avoids hospitalization and death in 90 percent of the people to whom it is applied.”

He recalled that it continues with phase III of the clinical trials of its biological in Mexico, in which 15 thousand volunteers from Mexico participate, and as soon as final results are obtained, modifications related to the number of necessary doses of the vaccine will be made.

So far, Mexico has received almost 13 million doses of CanSino out of a total of 35 million acquired and with this drug, the Government vaccinated all public and private educational personnel in the 32 states of the country.

Mexico has supplied a total of 71.6 million vaccines of various drugs in a country of 126 million people, although only 27.13 have a complete schedule.

In addition to CanSino, the country has committed 34.4 million doses of the American Pfizer, 79.4 million of the Anglo-Swedish AstraZeneca, 24 million of the Russian Sputnik V, 20 million of the Chinese Sinovac, 12 million of the also Chinese Sinopharm and 51.4 million of the WHO’s Covax platform.

With information from EFE


Disclaimer: If you need to update/edit/remove this news or article then please contact our support team Learn more